Gregory S. Patrick, VP, Chief Financial Officer at SUPERNUS PHARMACEUTICALS INC (SUPN), bought 5,000 shares at $6.95 ($35K) on 2013-03-14, disclosed to the SEC on 2013-03-15.
Scheduled purchase ($35k) by VP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| SUPN | SELL | 2020-10-15 | $300K | — | Filing → |
| SUPN | SELL | 2020-05-20 | $375K | — | Filing → |
| SUPN | SELL | 2020-05-11 | $347K | — | Filing → |